Literature DB >> 20923530

Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States.

Earl S Ford1, Guixiang Zhao, Chaoyang Li, William S Pearson.   

Abstract

BACKGROUND: Some reports suggest that concentrations of vitamin D are inversely, whereas concentrations of parathyroid hormone (PTH) are directly, associated with prevalent metabolic syndrome. Because of lingering uncertainty about these associations, we examined the cross-sectional associations between serum concentrations of 25-hydroxyvitamin D(3) and PTH with metabolic syndrome in a representative sample of adults in the US.
METHODS: We used data from 1705 participants in the 2005-2006 National Health and Nutrition Examination Survey. Vitamin D was measured by radioimmunoassay, whereas PTH was measured using an electrochemiluminescent process.
RESULTS: The mean concentration of vitamin D for participants with and without metabolic syndrome was 20.3 and 22.9 ng/mL, respectively (P = 0.001). The mean concentration of PTH for participants with and without metabolic syndrome was 44.5 and 41.0 pg/mL, respectively (P = 0.002). The age-adjusted mean concentrations of vitamin D (P for linear trend <0.001) decreased linearly, whereas PTH (P for linear trend = 0.002) increased linearly, as the number of components of metabolic syndrome increased. After adjusting for age, gender, physical activity, urinary albumin creatinine ratio, and concentrations of C-reactive protein and calcium, concentrations in the highest quintile of vitamin D [prevalence ratio (PR) = 0.59; 95% confidence interval (CI) 0.44-0.79], but not PTH (PR = 1.18; 95% CI 0.97-1.43), was significantly associated with prevalent metabolic syndrome.
CONCLUSION: Concentrations of vitamin D, but not PTH, were significantly associated with prevalent metabolic syndrome among US adults. Published 2009. This article is a US Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20923530     DOI: 10.1111/j.1753-0407.2009.00046.x

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  22 in total

1.  Comparative efficacy and safety of different doses of ergocalciferol supplementation in patients with metabolic syndrome.

Authors:  Nakarin Sansanayudh; Supakit Wongwiwatthananukit; Nongluk Phetkrajaysang; Sarinee Krittiyanunt
Journal:  Int J Clin Pharm       Date:  2014-05-23

2.  Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women.

Authors:  Sara A Chacko; Yiqing Song; JoAnn E Manson; Linda Van Horn; Charles Eaton; Lisa W Martin; Anne McTiernan; J David Curb; Judith Wylie-Rosett; Lawrence S Phillips; Raymond A Plodkowski; Simin Liu
Journal:  Am J Clin Nutr       Date:  2011-05-25       Impact factor: 7.045

3.  Association between light exposure and metabolic syndrome in a rural Brazilian town.

Authors:  Ana Amélia Benedito-Silva; Simon Evans; Juliana Viana Mendes; Juliana Castro; Bruno da Silva B Gonçalves; Francieli S Ruiz; Felipe Beijamini; Fabiana S Evangelista; Homero Vallada; Jose Eduardo Krieger; Malcolm von Schantz; Alexandre C Pereira; Mario Pedrazzoli
Journal:  PLoS One       Date:  2020-09-18       Impact factor: 3.240

4.  Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients.

Authors:  David J Friedman; Nisha Bhatt; Najwah S Hayman; Brendan J Nichols; Mark Herman; Nikolay Nikolaev; John Danziger
Journal:  Clin Endocrinol (Oxf)       Date:  2012-07       Impact factor: 3.478

5.  Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components.

Authors:  Jennifer W Bea; Peter W Jurutka; Elizabeth A Hibler; Peter Lance; Maria E Martínez; Denise J Roe; Christine L Sardo Molmenti; Patricia A Thompson; Elizabeth T Jacobs
Journal:  Metabolism       Date:  2014-11-29       Impact factor: 8.694

6.  Serum 25-hydroxyvitamin D, parathyroid hormone, and their association with metabolic syndrome in Chinese.

Authors:  Li-Hua Li; Xue-Yan Yin; Chao-Yong Yao; Xue-Chuang Zhu; Xin-Hua Wu
Journal:  Endocrine       Date:  2013-01-23       Impact factor: 3.633

7.  Associations between serum-intact parathyroid hormone, serum 25-hydroxyvitamin D, oral vitamin D analogs and metabolic syndrome in peritoneal dialysis patients: a multi-center cross-sectional study.

Authors:  Jie Dong; Qin Wang; Meng-Hua Chen; Hui-Ping Zhao; Tong-Ying Zhu; Na Tian; Mei Wang; Chuan-Ming Hao; Ye-Ping Ren; Hai-Yan Wang
Journal:  Perit Dial Int       Date:  2014-02-04       Impact factor: 1.756

8.  Association between serum vitamin D, parathyroid hormone and metabolic syndrome in middle-aged and older Korean adults.

Authors:  J Kim
Journal:  Eur J Clin Nutr       Date:  2014-09-24       Impact factor: 4.016

9.  Association between metabolic syndrome, BMI, and serum vitamin D concentrations in rheumatoid arthritis.

Authors:  Ladan Goshayeshi; HamidReza Saber; Maryam Sahebari; Zahra Rezaieyazdi; Houshang Rafatpanah; Habibollah Esmaily; Lena Goshayeshi
Journal:  Clin Rheumatol       Date:  2012-05-13       Impact factor: 2.980

10.  VITAMIN DEFICIENCY AND INSULIN RESISTANCE IN NONDIABETIC OBESE PATIENTS.

Authors:  O Cigerli; H Parildar; A Dogruk Unal; O Tarcin; A Kut; H Eroglu; N Guvener
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.